Suppr超能文献

阿普唑仑与丙咪嗪治疗抑郁症的双盲对照评估

A double-blind evaluation of alprazolam and imipramine in the treatment of major depression.

机构信息

Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore 560029.

出版信息

Indian J Psychiatry. 1991 Apr;33(2):104-7.

Abstract

This report describes the results of a multicentre collaborative study comparing the safety and efficacy of alprazolam with imipramine in patients suffering from major depressive disorder. Two hundred and eight patients diagnosed as major depression as per DSM-III criteria were randomly allocated to alprazolam (N= 105) or imipramine (N = 103) in a double-blind fashion. Detailed assessments were carried out for a period of six weeks. Results revealed that alprazolam was as effective as imipramine as an antidepressant. Side effects were less frequently reported with alprazolam.

摘要

本报告描述了一项多中心合作研究的结果,该研究比较了阿普唑仑和丙咪嗪在患有重度抑郁症患者中的安全性和疗效。根据 DSM-III 标准诊断为重度抑郁症的 208 例患者被随机分配至阿普唑仑(N=105)或丙咪嗪(N=103)组,采用双盲法。详细评估持续 6 周。结果表明,阿普唑仑作为抗抑郁药与丙咪嗪同样有效。阿普唑仑的副作用报告较少。

相似文献

引用本文的文献

2
Alprazolam for depression.用于治疗抑郁症的阿普唑仑。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007139. doi: 10.1002/14651858.CD007139.pub2.
3
An overview of Indian research in anxiety disorders.焦虑障碍相关印度研究概述。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S210-8. doi: 10.4103/0019-5545.69234.

本文引用的文献

1
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
2
The assessment of anxiety states by rating.通过评分对焦虑状态进行评估。
Br J Med Psychol. 1959;32(1):50-5. doi: 10.1111/j.2044-8341.1959.tb00467.x.
7
Diagnostic criteria for use in psychiatric research.精神科研究中使用的诊断标准。
Arch Gen Psychiatry. 1972 Jan;26(1):57-63. doi: 10.1001/archpsyc.1972.01750190059011.
9
Discontinuation of alprazolam treatment in panic patients.惊恐障碍患者停用阿普唑仑治疗
Am J Psychiatry. 1987 Mar;144(3):303-8. doi: 10.1176/ajp.144.3.303.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验